Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonparametric density estimation applied to population pharmacokinetics

L Claret1, A Iliadis

  • 1Laboratoire de Pharmacocinétique, Faculté de Pharmacie, Marseille, France.

Mathematical Biosciences
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clamped percutaneous Poller screws to assist intramedullary nailing of proximal third tibia shaft fractures.

Annals of the Royal College of Surgeons of England·2022
Same author

Model-Based Estimates of Tumor Growth Inhibition Metrics Are Time-Independent: A Reply to Mistry.

CPT: pharmacometrics & systems pharmacology·2016
Same author

Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma.

Clinical pharmacology and therapeutics·2016
Same author

Bilateral Internuclear Ophthalmoplegia as a Presenting Manifestation of Primary Sjögren's Syndrome.

Neuro-ophthalmology (Aeolus Press)·2016
Same author

Simulations to Predict Clinical Trial Outcome of Bevacizumab Plus Chemotherapy vs. Chemotherapy Alone in Patients With First-Line Gastric Cancer and Elevated Plasma VEGF-A.

CPT: pharmacometrics & systems pharmacology·2016
Same author

A Tumor Growth Inhibition Model Based on M-Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single-Agent Carfilzomib Use.

CPT: pharmacometrics & systems pharmacology·2016
Same journal

Intelligent machine learning solutions with Bayesian regularization backpropagation adaptive networks for differential systems of Maize streak virus diseases.

Mathematical biosciences·2026
Same journal

The stability and bifurcations of ecosystems within resource constraints - Dedicated to Professor Shigui Ruan on the occasion of his 60th birthday.

Mathematical biosciences·2026
Same journal

The hydra and hormetic effects in a single discrete-time overcompensation model.

Mathematical biosciences·2026
Same journal

Seasonal impacts on brucellosis transmission mediated by live sheep supply-demand dynamics.

Mathematical biosciences·2026
Same journal

Optimal controls and cost-effectiveness analysis on the transmission dynamics of early blight disease in tomatoes.

Mathematical biosciences·2026
Same journal

Temperature-dependent dynamics and allee effect thresholds mediate fourfold cusp stability in biological control of invasive vectors.

Mathematical biosciences·2026
See all related articles

This study introduces a novel nonparametric method for pharmacokinetic population studies. It uses joint probability density functions and information theory to better understand drug variability and covariate relationships.

Area of Science:

  • Pharmacokinetics
  • Pharmacometrics
  • Biostatistics

Background:

  • Population pharmacokinetic studies analyze drug absorption, distribution, metabolism, and elimination (ADME) variability.
  • Traditional methods often rely on linear regression to link kinetic parameters with covariates like age and weight.
  • Existing approaches may not fully capture complex interindividual variability and covariate relationships.

Purpose of the Study:

  • To develop a novel nonparametric approach for estimating interindividual variability in pharmacokinetic parameters.
  • To utilize joint probability density functions and information theory for improved covariate analysis.
  • To enhance Bayesian estimation by incorporating nonparametric conditional probability density functions.

Main Methods:

Related Experiment Videos

  • Estimation of joint probability density functions using a nonparametric kernel-based method.
  • Application of Shannon information theory to determine sample size and identify informative covariates.
  • Derivation of nonparametric conditional probability density functions of kinetic parameters given covariates.
  • Simulation study to assess the feasibility and performance of the proposed method, including nonlinear covariate relationships.

    • Main Results:

    • The proposed nonparametric method effectively describes interindividual variability and covariate dependencies.
    • Shannon information theory aids in optimizing study design by determining necessary sample sizes and screening relevant covariates.
    • Nonparametric conditional probability density functions provide valuable prior information for Bayesian analysis.
    • The new covariate-based estimator demonstrated competitive performance compared to standard Bayesian estimation in simulations.

    Conclusions:

    • The developed nonparametric approach offers a robust alternative for population pharmacokinetic modeling.
    • This method provides a more comprehensive understanding of drug variability and covariate influences.
    • The integration of information theory and nonparametric density estimation enhances the efficiency and informativeness of pharmacokinetic studies.